Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2003 Oct;58(10):835–839. doi: 10.1136/thorax.58.10.835

Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

L Tata 1, J West 1, T Harrison 1, P Farrington 1, C Smith 1, R Hubbard 1
PMCID: PMC1746473  PMID: 14514932

Abstract

Background: Concern over the safety of influenza vaccination in individuals with obstructive airways disease has contributed to suboptimal rates of vaccine uptake in this group. We investigated the safety of influenza vaccine in older people with asthma or chronic obstructive pulmonary disease (COPD) in a cohort from the UK General Practice Research Database (GPRD).

Methods: A population based cohort study of 12 000 individuals with asthma or COPD from 432 general practices was conducted. Incidence rate ratios (IRR) were calculated for asthma or COPD diagnoses, prescriptions for oral corticosteroids, and acute exacerbations on the day of vaccination and on days 1–2 and 3–14 after vaccination compared with other time periods in the influenza season.

Results: The IRRs for asthma or COPD diagnoses and oral corticosteroid prescriptions were increased on the day of vaccination (for example, the IRR for oral corticosteroid prescriptions for subjects with asthma during the 1992–3 influenza season was 8.24 (95% confidence interval 5.54 to 12.26)). However, there was no consistent increase in the IRR of any of the outcomes on days 1–2 or 3–14 after vaccination, and most of these IRRs were close to 1. Rates of exacerbation were low and showed no consistent statistically significant increase during any risk periods.

Conclusions: Older people with asthma or COPD commonly have diagnoses recorded or prescriptions for oral corticosteroids given on the day of influenza vaccination, but there is no increased risk of adverse acute outcomes in the first 2 weeks after vaccination. Our findings strongly suggest that influenza vaccination is safe in this population.

Full Text

The Full Text of this article is available as a PDF (216.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. E., Nicholson K. G., Nguyen-Van-Tam J. S. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet. 1995 Sep 2;346(8975):591–595. doi: 10.1016/s0140-6736(95)91434-x. [DOI] [PubMed] [Google Scholar]
  2. Ahmed A. H., Nicholson K. G., Nguyen-van Tam J. S., Pearson J. C. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect. 1997 Feb;118(1):27–33. doi: 10.1017/s0950268896007121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cates C. J., Jefferson T. O., Bara A. I., Rowe B. H. Vaccines for preventing influenza in people with asthma (Cochrane Review). Cochrane Database Syst Rev. 2000;(4):CD000364–CD000364. doi: 10.1002/14651858.CD000364. [DOI] [PubMed] [Google Scholar]
  4. Farrington C. P., Nash J., Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol. 1996 Jun 1;143(11):1165–1173. doi: 10.1093/oxfordjournals.aje.a008695. [DOI] [PubMed] [Google Scholar]
  5. Farrington P., Pugh S., Colville A., Flower A., Nash J., Morgan-Capner P., Rush M., Miller E. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995 Mar 4;345(8949):567–569. doi: 10.1016/s0140-6736(95)90471-9. [DOI] [PubMed] [Google Scholar]
  6. Fine P. E., Chen R. T. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol. 1992 Jul 15;136(2):121–135. doi: 10.1093/oxfordjournals.aje.a116479. [DOI] [PubMed] [Google Scholar]
  7. García Rodríguez L. A., Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol. 1998 May;45(5):419–425. doi: 10.1046/j.1365-2125.1998.00701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gorse G. J., Otto E. E., Daughaday C. C., Newman F. K., Eickhoff C. S., Powers D. C., Lusk R. H. Influenza virus vaccination of patients with chronic lung disease. Chest. 1997 Nov 5;112(5):1221–1233. doi: 10.1378/chest.112.5.1221. [DOI] [PubMed] [Google Scholar]
  9. Govaert T. M., Dinant G. J., Aretz K., Masurel N., Sprenger M. J., Knottnerus J. A. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 1993 Oct 16;307(6910):988–990. doi: 10.1136/bmj.307.6910.988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Govaert T. M., Thijs C. T., Masurel N., Sprenger M. J., Dinant G. J., Knottnerus J. A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994 Dec 7;272(21):1661–1665. [PubMed] [Google Scholar]
  11. Gross P. A., Hermogenes A. W., Sacks H. S., Lau J., Levandowski R. A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995 Oct 1;123(7):518–527. doi: 10.7326/0003-4819-123-7-199510010-00008. [DOI] [PubMed] [Google Scholar]
  12. Hak E., Hoes A. W., Grobbee D. E., Lammers J. W. J., van Essen G. A., van Loon A. M., Verheij T. J. M. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am J Epidemiol. 2003 Apr 15;157(8):692–700. doi: 10.1093/aje/kwg027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hansell A., Hollowell J., Nichols T., McNiece R., Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax. 1999 May;54(5):413–419. doi: 10.1136/thx.54.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kramarz P., DeStefano F., Gargiullo P. M., Davis R. L., Chen R. T., Mullooly J. P., Black S. B., Bohlke K., Ward J. I., Marcy M. S. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine. 2000 Apr 28;18(21):2288–2294. doi: 10.1016/s0264-410x(99)00551-4. [DOI] [PubMed] [Google Scholar]
  15. Kramarz P., DeStefano F., Gargiullo P. M., Davis R. L., Chen R. T., Mullooly J. P., Black S. B., Shinefield H. R., Bohlke K., Ward J. I. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team. Arch Fam Med. 2000 Jul;9(7):617–623. doi: 10.1001/archfami.9.7.617. [DOI] [PubMed] [Google Scholar]
  16. Lawson D. H., Sherman V., Hollowell J. The General Practice Research Database. Scientific and Ethical Advisory Group. QJM. 1998 Jun;91(6):445–452. doi: 10.1093/qjmed/91.6.445. [DOI] [PubMed] [Google Scholar]
  17. Margolis K. L., Nichol K. L., Poland G. A., Pluhar R. E. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA. 1990 Sep 5;264(9):1139–1141. [PubMed] [Google Scholar]
  18. Nguyen-Van-Tam J. S., Nicholson K. G. Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season. Epidemiol Infect. 1993 Oct;111(2):347–355. doi: 10.1017/s0950268800057058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nichol K. L., Margolis K. L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994 Sep 22;331(12):778–784. doi: 10.1056/NEJM199409223311206. [DOI] [PubMed] [Google Scholar]
  20. Nicholson K. G., Nguyen-Van-Tam J. S., Ahmed A. H., Wiselka M. J., Leese J., Ayres J., Campbell J. H., Ebden P., Eiser N. M., Hutchcroft B. J. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet. 1998 Jan 31;351(9099):326–331. doi: 10.1016/S0140-6736(97)07468-0. [DOI] [PubMed] [Google Scholar]
  21. Nicholson K. G., Snacken R., Palache A. M. Influenza immunization policies in Europe and the United States. Vaccine. 1995 Mar;13(4):365–369. doi: 10.1016/0264-410x(95)98258-c. [DOI] [PubMed] [Google Scholar]
  22. Poole P. J., Chacko E., Wood-Baker R. W., Cates C. J. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2000;(4):CD002733–CD002733. doi: 10.1002/14651858.CD002733. [DOI] [PubMed] [Google Scholar]
  23. Rothbarth P. H., Kempen B. M., Sprenger M. J. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995 May;151(5):1682–1686. doi: 10.1164/ajrccm/151.5_Pt_1.1682. [DOI] [PubMed] [Google Scholar]
  24. Soriano J. B., Maier W. C., Visick G., Pride N. B. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol. 2001;17(12):1075–1080. doi: 10.1023/a:1021235123382. [DOI] [PubMed] [Google Scholar]
  25. Stenius-Aarniala B., Huttunen J. K., Pyhälä R., Haahtela T., Jokela P., Jukkara A., Karakorpi T., Kataja M., Kava T., Kuusisto P. Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus. Chest. 1986 Jun;89(6):786–789. doi: 10.1378/chest.89.6.786. [DOI] [PubMed] [Google Scholar]
  26. Wijnhoven H. A., Kriegsman D. M., Hesselink A. E., Penninx B. W., de Haan M. Determinants of different dimensions of disease severity in asthma and COPD : pulmonary function and health-related quality of life. Chest. 2001 Apr;119(4):1034–1042. doi: 10.1378/chest.119.4.1034. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES